Response of central nervous system aspergillosis to voriconazole

Neurology India

Volumn 55, Issue 3, 2007, Pages 301-303

  Balasubramaniam, Prakash ^a,b   Madakira, Pranesh ^a   Ninan, Anish ^a   Swaminathan, Aarthi ^a  

^a PSG INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

^b NONE   (India)

Author keywords

Aspergilloma; Aspergillosis; Fungal granuloma; Voriconazole

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ITRACONAZOLE; VORICONAZOLE;

AGED; ANAMNESIS; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; BRAIN ABSCESS; BRAIN INFECTION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG COST; FUNGUS IDENTIFICATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; LENGTH OF STAY; MALE; MENINGITIS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PARANASAL SINUS; PHYSICAL EXAMINATION; UNSPECIFIED SIDE EFFECT;

EID: 35048849384     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.35694     Document Type: Article

References (6)

1. Davis LE. Fungal infections of the central nervous system. Neurol Clin 1999;17:761-81.
2. Sundaram C, Umabala P, Laxmi V, Purohit AK, Prasad VS, Panigrahi M, et al. Pathology of fungal infections of the central nervous system: 17 years experience from Southern India. Histopathology 2006;49:396-405.
3. Schwartz S, Thiel E. CNS-Aspergillosis: Are there new treatment options? Mycoses 2003;46:8-14.
4. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15.
5. Clemons KV, Espiritu M, Parmar R, Stevens DA. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrobial Agents Chemother 2005;49:4867-75.
6. Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR, Graybill R, et al. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial. Clin Infect Dis 2007;44:2-12.